Skip to main content
Home
Student Life
Students Support
Guidance & Counselling
Mentorship
Staff
Academic
Administrative
Support
Technical
Outreach Activities
Reports
Patents and Trademark
Policy Briefs
Staff Welfare
UON @ 50
Awards & Achievements
Articles
Webinars
Resources
Teaching Venues
Library
Facilities & Equipment
Search
Department of Medical Microbiology & Immunology
UNIVERSITY OF NAIROBI
About Us
Brief History
Mission, Vision, Core Values
Message from HoD
Physical Location
Annual Report
Governance
Partners and Collaborators
Infrastructure
Service Charter
Programmes
How to Apply
Masters
Doctor of Philosophy (PhD)
Post Graduate Diploma
Number of Students per Programme
News
Latest News
Research
Research News
Journals
Research Projects
Past
Current
Collaborators
Seminar & Conferences
Media
Covid-19 Updates
Gallery
ADMISSION
ONLINE REGISTRATION
Graduate Education
Undergraduate Education
Breadcrumb
/
Home
/
Journals
/
Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Nairobi, Kenya
Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Nairobi, Kenya
Link to Journal Site
View Journal
